{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T16:09:30Z","timestamp":1725725370330},"publisher-location":"Boston, MA","reference-count":38,"publisher":"Springer US","isbn-type":[{"type":"print","value":"9781475792119"},{"type":"electronic","value":"9781475792096"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1996]]},"DOI":"10.1007\/978-1-4757-9209-6_3","type":"book-chapter","created":{"date-parts":[[2013,5,6]],"date-time":"2013-05-06T08:11:56Z","timestamp":1367827916000},"page":"17-31","source":"Crossref","is-referenced-by-count":4,"title":["Famciclovir: Efficacy in Zoster and Issues in the Assessment of Pain"],"prefix":"10.1007","author":[{"given":"Ronald J.","family":"Boon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David R. J.","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"3_CR1","doi-asserted-by":"crossref","unstructured":"Whitley RJ. Antiviral therapy: the time has come. J Med Virol 1993; Suppl 1: 1.","DOI":"10.1002\/jmv.1890410502"},{"key":"3_CR2","first-page":"729","volume":"40","author":"RJ Whitley","year":"1992","unstructured":"Whitley RJ. Neonatal herpes simplex virus infections: pathogenesis and therapy. Pathol Biol (Paris) 1992; 40: 729\u2013734.","journal-title":"Pathol Biol (Paris)"},{"key":"3_CR3","doi-asserted-by":"crossref","unstructured":"Whitley RI Neonatal herpes simplex virus infections. J Med Virol 1993; Suppl 1: 13\u201321.","DOI":"10.1002\/jmv.1890410505"},{"key":"3_CR4","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1038\/clpt.1993.196","volume":"54","author":"S Weller","year":"1993","unstructured":"Weller S, Blum MR, Doucette M, Burnette T, Cederberg DM, de Miranda P and Smiley ML. Pharmacokinetics of the acyclovir pro-drug valaciclovir after escalating single-and multiple-dose administration to normal volunteers. Clin Pharmacol Ther 1993; 54: 596\u2013605.","journal-title":"Clin Pharmacol Ther"},{"key":"3_CR5","first-page":"146","volume":"9","author":"MR Boyd","year":"1988","unstructured":"Boyd MR, Boon R, Fowles SE, et al. Some biological properties of BRL 42810, a well-absorbed oral prodrug of the anti-herpesvirus agent BRL 39123.(Abstract) Antiviral Res 1988; 9: 146.","journal-title":"Antiviral Res"},{"issue":"1","key":"3_CR6","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/09563202930040S602","volume":"4","author":"MA Pue","year":"1993","unstructured":"Pue MA and Benet LZ. Pharmacokinetics of famciclovir in man. Antiviral Chem Chemother 1993; 4: (Suppl 1) 47\u201355.","journal-title":"Antiviral Chem Chemother"},{"key":"3_CR7","first-page":"59","volume":"58","author":"RE Hope-Simpson","year":"1964","unstructured":"Hope-Simpson RE (1964). The nature of herpes zoster: a long term study and a new hypothesis. Proceedings of the Royal Society of Medicine 58: 59.","journal-title":"Proceedings of the Royal Society of Medicine"},{"key":"3_CR8","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1128\/AAC.33.10.1765","volume":"33","author":"RA Hodge","year":"1989","unstructured":"Vere Hodge RA, Sutton D, Boyd MR, Hamden MR and Jarvest RL. Selection of an oral prodrug (BRL 42810; Famciclovir) for the antiherpesvirus agent BRL 39123 [9-(4-hydroxy-3-hydroxymethylbut-1-yl) guanine; penciclovir]. Antimicrob Agents Chemother 1989; 33: 1765\u20131773.","journal-title":"Antimicrob Agents Chemother"},{"key":"3_CR9","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1128\/AAC.31.8.1238","volume":"31","author":"MR Boyd","year":"1987","unstructured":"Boyd MR, Bacon TH, Sutton D and Cole M. Antiherpesvirus activity of 9-(4-hydroxy-3-hydroxymethylbut-l-yl) guanine (BRL 39123) in cell culture. Antimicrob Agents Chemother 1987; 31: 1238\u20131242.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"3_CR10","first-page":"99","volume":"23","author":"TH Bacon","year":"1994","unstructured":"Bacon TH and Boyd MR. Comparative activity of penciclovir and acyclovir against Epstein-Barr Virus. Antiviral Res 1994; 23 (Suppl 1): 99.","journal-title":"Antiviral Res"},{"issue":"1","key":"3_CR11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/095632029300401S01","volume":"4","author":"MR Boyd","year":"1993","unstructured":"Boyd MR, Safrin S and Kern ER. Penciclovir: a review of its spectrum of activity, selectivity, and cross-resistance pattern. Antiviral Chem Chemother 1993; 4 (Suppl 1): 3\u201311.","journal-title":"Antiviral Chem Chemother"},{"key":"3_CR12","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1128\/AAC.33.2.223","volume":"33","author":"RA Hodge","year":"1989","unstructured":"Vere Hodge RA and Perkins RM. Mode of action of 9-(4-hydroxy-3-hydroxymethylbut-1-yl) guanine (BRL 39123) against herpes simplex virus in MRC-5 cells. Antimicrob Agents Chemother 1989; 33: 223\u2013229.","journal-title":"Antimicrob Agents Chemother"},{"key":"3_CR13","first-page":"2747","volume":"36","author":"DL Earnshaw","year":"1992","unstructured":"Earnshaw DL, Bacon TH, Darlison SJ, Edmunds K, Perkins RM and Vere Hodge RA. Mode of antiviral action of penciclovir in MRC-5 cells infected with herpes simplex virus type 1 (HSV-1), HSV-2, and varicella-zoster virus. Antimicrob Agents Chemother 1992; 36: 2747\u20132757.","journal-title":"Mode of antiviral action of penciclovir in MRC-5 cells infected with herpes simplex virus type 1 (HSV-1), HSV-2, and varicella-zoster virus. Antimicrob Agents Chemother"},{"key":"3_CR14","unstructured":"Standring-Cox R, Bacon TH, Howard BA, Gilbart J, Boyd MR. Comparison of the activity of penciclovir and acyclovir against varicella-zoster virus in cell culture (Abstract 73). In: Book of Abstracts of the 6th International Congress for Infectious Diseases. Prague, 1994."},{"issue":"1","key":"3_CR15","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/09563202930040S601","volume":"4","author":"RA Hodge","year":"1993","unstructured":"Vere Hodge RA and Cheng Y.-C. The mode of action of penciclovir. Antiviral Chem Chemother 1993; 4 (Suppl 1): 13\u201324.","journal-title":"Antiviral Chem Chemother"},{"key":"3_CR16","unstructured":"Pratt SK, Fairless AJ, Pue MA, Hucker RS, Collie H and Sourgens H. The absolute bioavailability of the antiviral compound, penciclovir, following a single oral administration of 500 mg famiciclovir. European Acadamy of Dermatology and Venereology Congress, Copenhagen., 27\u201330 September 1993 ( Poster)."},{"key":"3_CR17","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/jac\/33.1.119","volume":"33","author":"MA Pue","year":"1994","unstructured":"Pue MA, Pratt SK, Fairless M, Fowles S, Laroche J, Georgiou P and Prince W. Linear pharmacokinetics of penciclovir following administration of single oral doses of famciclovir 125, 250, 500 and 750 mg to healthy volunteers. J Antimicrob Chemother 1994; 33: 119\u2013127.","journal-title":"J Antimicrob Chemother"},{"key":"3_CR18","first-page":"450","volume":"35","author":"SE Fowles","year":"1993","unstructured":"Fowles SE, Pue MA, Pierce D. et al. Pharmacokinetics of penciclovir in healthy elderly subjects following a single oral administration of 750 mg famciclovir. Br J Clin Pharmacol 1993; 35: 450","journal-title":"Br J Clin Pharmacol"},{"key":"3_CR19","unstructured":"Pratt SK, Beerahee M, Pue MA, Hucker R, Laroche J, Scott, S and Gross G. The pharmacokinetics of famciclovir following oral administration of 500 mg famciclovir to patients with uncomplicated herpes zoster. European Acadamy of Dermatology and Venereology Congress, Copenhagen, 27\u201330 September 1993 ( Poster)."},{"key":"3_CR20","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1111\/j.1834-7819.1990.tb00780.x","volume":"35","author":"AP Barrait","year":"1990","unstructured":"Barrait AP. Herpes zoster virus infection. A clinicopathologic review and case reports. Australian Dental J. 1990; 35: 328\u2013332.","journal-title":"Australian Dental J"},{"key":"3_CR21","unstructured":"Tyring S, Nahlik J, Cunningham A, Marley J, Heng M, Rea T and the Famciclovir Herpes Zoster Clinical Study Group. Efficacy and safety of famciclovir in the treatment of patients with herpes zoster: results of the first placebo-controlled study (Abstract 1540). In: Program and Abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy. New Orleans. American Society of Microbiology, 1993."},{"key":"3_CR22","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/0924-8579(94)90024-8","volume":"4","author":"H Degreef","year":"1994","unstructured":"Degreef H and Famciclovir Herpes Zoster Clinical Study Group. Famciclovir, a new oral antiherpes drug: results of the first controlled clinical study demonstrating its efficacy and safety in the treatment of uncomplicated herpes zoster in immunocompetent patients. Int J Antimicrobial Agents 1994; 4: 241\u2013246.","journal-title":"Int J Antimicrobial Agents"},{"key":"3_CR23","unstructured":"International Herpes Management Forum. How can the burden of zoster-associated pain be reduced? Recommendations from the IHMF Management Strategies Workshop, Washington DC, 15th May 1993."},{"key":"3_CR24","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1097\/00002508-198809000-00007","volume":"4","author":"BB Bhala","year":"1988","unstructured":"Bhala BB, Ramamoorthy C, Bowsher D, Yelnoorker KN. Shingles and post-herpetic neuralgia. Clin J Pain 1988; 4: 169\u2013174.","journal-title":"Clin J Pain"},{"key":"3_CR25","unstructured":"Bean B, Deamant C, Aeppli D. Acute zoster: course, complications and treatment in the immunocompetent host. In Pain Research and Clinical Managment 1993 Volume 8: 37\u201358. \u201cHerpes Zoster and Post-herpetic Neuralgia\u201d Editor: CPN Watson, Elsevir, Amsterdam."},{"key":"3_CR26","doi-asserted-by":"crossref","unstructured":"Huff JC, Drucker JL, Clemmer A et al. Effect of oral acyclovir on pain resolution in herpes zoster: a reanalysis. J Med Virol 1993; Suppl 1: 93\u201396.","DOI":"10.1002\/jmv.1890410518"},{"key":"3_CR27","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0304-3959(91)90076-A","volume":"46","author":"CN Watson","year":"1991","unstructured":"Watson CPN, Watt VR, Chipman M et al. The prognosis with postherpetic neuralgia. Pain 1991; 46: 195\u2013199.","journal-title":"Pain"},{"key":"3_CR28","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1001\/jama.1957.02980030041010","volume":"164","author":"CF Burgoon","year":"1957","unstructured":"Burgoon CF, Burgoon JS, Baldridge GD. The natural history of herpes zoster. JAMA 1957; 164: 265\u2013269.","journal-title":"JAMA"},{"issue":"1","key":"3_CR29","first-page":"73","volume":"23","author":"S Tyring","year":"1994","unstructured":"Tyring S. Barbarash R, Nahlik J, Cunningham A, Marley J, Heng M, Jones T. Rea. T. and the collaborative famciclovir herpes zoster clinical study group. Efficacy of famciclovir on herpes zoster rash resolution and post-herpetic neuralgia. Antiviral Research 1994; 23 (Suppl 1): 73.","journal-title":"Antiviral Research"},{"issue":"3","key":"3_CR30","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/jac\/34.3.307","volume":"34","author":"P Easterbrook","year":"1994","unstructured":"Easterbrook P and Wood MJ. Successors to acyclovir. JAC 1994; 34 (3): 307\u2013311.","journal-title":"JAC"},{"key":"3_CR31","first-page":"62","volume":"78","author":"RJ Crooks","year":"1991","unstructured":"Crooks RJ, Jones DA and Fiddian AP. Zoster-associated chronic pain: an overview of clinical trials with acyclovir. Scand J Infect 1991; Suppl 78: 62\u201368.","journal-title":"Scand J Infect"},{"key":"3_CR32","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1532-5415.1971.tb01208.x","volume":"19","author":"RS Rogers","year":"1971","unstructured":"Rogers RS and Tindall JP (1971). Geriatric herpes zoster. J Am Geriatr Soc 19: 495\u2013503.","journal-title":"J Am Geriatr Soc"},{"key":"3_CR33","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1097\/00007611-197605000-00028","volume":"69","author":"GR Brown","year":"1986","unstructured":"Brown GR. (1986) Herpes zoster: Correlation of age, sex, distribution, neuralgia and associated disorders. South Med J 69: 576\u2013578.","journal-title":"South Med J"},{"key":"3_CR34","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1001\/jama.1970.03170100043009","volume":"211","author":"WH Eaglstein","year":"1970","unstructured":"Eaglstein WH, Katz R, Brown JA. (1970). The effects of early corticosteroid therapy on the skin eruption and pain of herpes zoster. JAMA 211: 1681\u20131683.","journal-title":"JAMA"},{"key":"3_CR35","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1001\/archderm.1984.01650420057016","volume":"120","author":"JM Riopelle","year":"1984","unstructured":"Riopelle JM, Naraghi M, Grush KP. (1984). Chronic neuralgia incidence following local anaesthetic therapy for herpes zoster. Arch Dermatol 120: 747\u2013750.","journal-title":"Arch Dermatol"},{"key":"3_CR36","doi-asserted-by":"crossref","unstructured":"Dworkin RH, Boon RJ, Griffin DRJ (1995). Famciclovir: effect on pain in herpes zoster. Abstract 225. 8th International Conference on Antiviral Research, Santa Fe, New Mexico. April 23\u201328.","DOI":"10.1016\/0166-3542(95)94923-P"},{"key":"3_CR37","doi-asserted-by":"crossref","unstructured":"Dworkin RH, Boon RJ, Griffin DRJ (1995). Covariates in herpes zoster and interpretation of clinical trial data. Abstract 226. 8th International Conference on Antiviral Research, Santa Fe, New Mexico. April 23\u201328.","DOI":"10.1016\/0166-3542(95)94924-Q"},{"key":"3_CR38","doi-asserted-by":"crossref","unstructured":"Dworkin RH, Boon RJ, Griffin DRJ (1995). Famciclovir: effect on pain in herpes zoster. Abstract 225. 8th International Conference on Antiviral Research, Santa Fe, New Mexico. April 23\u201328.","DOI":"10.1016\/0166-3542(95)94923-P"}],"container-title":["Advances in Experimental Medicine and Biology","Antiviral Chemotherapy 4"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4757-9209-6_3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T14:19:28Z","timestamp":1688221168000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4757-9209-6_3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996]]},"ISBN":["9781475792119","9781475792096"],"references-count":38,"URL":"https:\/\/doi.org\/10.1007\/978-1-4757-9209-6_3","relation":{},"ISSN":["0065-2598"],"issn-type":[{"type":"print","value":"0065-2598"}],"subject":[],"published":{"date-parts":[[1996]]}}}